# Safety and Efficacy Study of NV-101 in Dental Patients

> **NCT00154167** · PHASE2 · COMPLETED · sponsor: **Novalar Pharmaceuticals, Inc.** · enrollment: 122 (—)

## Conditions studied

- Soft Tissue Anesthesia (Numbness)

## Interventions

- **DRUG:** NV-101 (phentolamine mesylate solution)

## Key facts

- **NCT ID:** NCT00154167
- **Lead sponsor:** Novalar Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** —
- **Final completion:** 2003-06
- **Target enrollment:** 122 (—)
- **Last updated:** 2005-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00154167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00154167, "Safety and Efficacy Study of NV-101 in Dental Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00154167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*